Frost: Strategic Analysis of the Opportunities for the Pharmaceutical and Biotechnology Industry in the 'New' EU Countries
Pharmaceutical and Biotechnology Industry in the 'New' EU Countries Presents Considerable Potential, Parallel Imports Remain a Challenge
25-Feb-2005 -
In contrast to subdued growth in the pharmaceutical markets of the former 15-state European Union (EU), pharmaceutical markets in the 'new' EU accession markets are expanding vibrantly. While the former has been increasing at eight per cent annually, the latter has been growing at the rate of ...
anti-infectives
biotechnology
central nervous system
+15